Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 (approx ₹ 2,200) per week, as it seeks to tap into the country’s rapidly expanding diabetes and obesity market, where demand for weight-loss treatments is soaring, Reuters reported.

Ozempic will be sold in a pen format in 0.25 mg, 0.5 mg and 1 mg doses, the drugmaker said. Also Read | Ozempic debut marks Novo Nordisk’s push to lead India’s obesity market

Novo set monthly prices at 8,800 rupees for the 0.25 mg dose, 10,170 rupees for 0.5 mg and 11,175 rupees for 1 mg. Each pen contains four weekly doses.

“Ozempic, a once-weekly injectable approved by the U.S. Food and Drug Administration in 2017 for type 2 diabetes, has become a global bestseller and is widely used off-label for weight loss due to

See Full Page